Skip to main content
Stephen Chung, MD, Hematology, Dallas, TX

StephenShiu-WahChungMD

Hematology Dallas, TX

Hematologic Oncology

Physician

Dr. Chung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chung's full profile

Already have an account?

  • Office

    6201 Harry Hines Blvd
    Dallas, TX 75390
    Phone+1 214-633-5555
    Fax+1 469-291-2736

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2006
  • Cornell University
    Cornell UniversityB.A., Biology, Concentration in Biochemistry, 2001

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2018 - 2026
  • NY State Medical License
    NY State Medical License 2009 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Tito Bastianello Young Investigator Award MDS Foundation, 2017
  • Paul Sherlock Housestaff Teaching Award, Department of Medicine MSKCC, 2017
  • Early Career Award in Myelodysplastic Syndrome Research Dresner Foundation, 2017
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • CD99 is a Therapeutic Target on Disease Stem Cells in Myeloid Malignancies  
    Chung SS, Eng WS, Hu W, Khalaj M, Garrett-Bakelman FE, Tavakkoli M, Levine RL, Carroll M, Klimek VM, Melnick AM, Park CY, Sci Transl Med, 1/1/2017
  • MicroRNA Dysregulation in the Myelodysplastic Syndromes  
    Chung SS, Park CY, MicroRNA, 1/1/2013
  • A 75- year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma)  
    Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ, Semin Oncol, 1/1/2012
  • Join now to see all

Books/Book Chapters

Lectures

  • An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. 
    1/1/2017
  • An Analysis of the Transcriptional Response of Myelodysplastic Syndrome Stem Cells to Therapy at Single Cell Resolution. Session 636. Myelodysplastic Syndromes- Basic... 
    1/1/2016
  • CD99 is a Therapeutic Target on Disease Stem Cells in the Myelodysplastic Syndromes and Acute Myeloid Leukemia. Session 6: The Myelodysplastic Syndromes. 
    1/1/2014
  • Join now to see all

Press Mentions

  • Breakthrough Research Studies Are Unveiled at the MDS Foundation 14th International Symposium on Myelodysplastic Syndromes
    Breakthrough Research Studies Are Unveiled at the MDS Foundation 14th International Symposium on Myelodysplastic SyndromesMay 8th, 2017